
Join leading global experts and innovators in preclinical research for an exclusive forum dedicated to shaping the future of drug discovery. This premier event highlights groundbreaking advancements in biotechnology, genetically modified models, and state-of-the-art research technologies that are paving the way to advance biomedical research and, ultimately, human health.
Discover solutions to accelerate your research and drug development processes while connecting with industry leaders in a collaborative, innovation-driven environment.




- Engage with Thought Leaders: Participate in sessions led by pioneers in biotechnology and preclinical research.
- Build Your Network: Connect with global experts, explore partnership opportunities, and expand your professional network.
- Experience Cutting-Edge Facilities: Tour Cyagen's AAALAC-accredited, OLAW-assured facilities to see our work in action.
- Innovative Research Models: Learn about cutting-edge in vivo and in vitro solutions that redefine industry standards.
- Strategic Insights: Discover the potential of HUGO-GT™ fully humanized mice for gene therapy and HUGO-Ab™ mice for therapeutic antibody discovery.
- Advanced Platforms: Learn about our one-stop CRO solutions for preclinical drug efficacy studies, cell biology, and colony management.
- AI-Powered Resources: Uncover applications of our AI-driven tools, such as the Rare Disease Data Center and AbSeq antibody sequencing.








- Find all the essential information you need below:
- Covered Expenses: Local accommodations, meals, and transportation will be provided. Attendees are responsible for their travel arrangements to the venue.
- Visa Assistance: Need help with your visa application? We’re here to assist. Complete the registration below and send us your assistance request
- Request an Invitation: This event is exclusive to professional researchers and industry partners. Participation is by invitation only and spaces are limited, so register now to secure your spot!
After review, qualified participants will receive a formal invitation to attend this exclusive event by February 10, 2025.
Participation is by invitation only, and registration will be reviewed before formal invitations are sent.